Evolent Health, Inc. (EVH)

Evolent Health, Inc. is trading at $4.25, down 5.56% on the session. The 50 day average sits at $4.76 and the 200 day at $3.86, which puts the stock in a uptrend. RSI is at 52.3, which reads as neutral, and MACD is bullish crossover. Volume is below average.

The nearest support is around $4.31 with resistance near $4.74, so that band frames the current range. Average daily movement is roughly $0.35, or about 8.2% of the share price, which is what any stop placement has to allow for. The overall health score of 59 out of 100 combines a trend score of 61, momentum of 78 and a risk score of 30.

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.